AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
AAC Accepts, published online ahead of print on 5 May 2008
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
AAC.00223-08v1
52/7/2564    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Ribeiro, R. R.
Right arrow Articles by Michalick, M. S.M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ribeiro, R. R.
Right arrow Articles by Michalick, M. S.M.
Antimicrob. Agents Chemother. doi:10.1128/AAC.00223-08
Copyright (c) 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Reduced tissue parasitic load and infectivity to sand flies in dogs naturally infected by Leishmania (Leishmania) chagasi following treatment with a liposome formulation of meglumine antimoniate

Raul R. Ribeiro, Eliane P. Moura, Vitor M. Pimentel, Weverton M. Sampaio, Sydnei M. Silva, Dante A. Schettini, Cintia F. Alves, Ferdinan A. Melo, Wagner L. Tafuri, Cynthia Demicheli, Maria N. Melo, Frédéric Frézard, and Marilene S.M. Michalick*

Departamento de Parasitologia, ICB; Faculdade de Farmácia; Departamento de Patologia Geral, ICB; Departamento de Fisiologia e Biofísica, ICB; Departamento de Química, ICEX; Av. Antônio Carlos 6627, Universidade Federal de Minas Gerais, 31270-901 Belo Horizonte, Minas Gerais, Brazil

* To whom correspondence should be addressed. Email: michalik{at}icb.ufmg.br.


   Abstract

The toxicity and antileishmanial effectiveness of a novel liposome formulation of meglumine antimoniate have been investigated in mongrel dogs with visceral leishmaniasis (VL) obtained from an endemic region for VL in Brazil. Groups of 12 animals received by i.v. route four doses (with 4 days-intervals) of either liposomal meglumine antimoniate (GI, 6.5 mg Sb/kg/dose), empty liposomes (GII) or isotonic saline (GIII). Evaluation of markers of hematopoietic, hepatic and renal functions before and just after treatment showed no significant change. On the other hand, transitory adverse reactions, including prostration, defecation, tachypnea and sialorrhea, were observed during the first 15 min after injections in GI and GII. Parasitological evaluation of sternal bone marrow four days after the last dose showed a significant reduction of parasite burden in GI, compared to the other groups. Immunocytochemical evaluations of the skin, bone marrow, cervical lymph nodes, liver and spleen of dogs for parasites, 150 days after treatment, indicated significant parasite suppressions (higher than 95.7%) in the lymph nodes, liver and spleen of GI, when compared to control groups. Feeding of Lutzomyia (L.) longipalpis phlebotomines on dogs from GI, 150 days after treatment, resulted in a significant reduction of sand fly infection efficiency, when compared to feeding on animals from GII and GIII. This is the first report of both long-term parasite suppression and reduction of infectivity to sand flies in naturally-infected dogs, following treatment with a liposome-encapsulated drug. Importantly, this was achieved using 20-fold lower cumulative dose of Sb, when compared to conventional antimonial treatment.







Home Help [Feedback] [For Subscribers] [Archive] [Search] --
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2008 by the American Society for Microbiology. All rights reserved.